@d.uf9: كرات بطاطس بطريقه مبتكره❤️‍🔥 الطريقه نسلق البطاطس الين يستوي ونضيف له ملعقتين جبن ورشه فلفل اسود وملح للدجاج بصل نشوحه ونضيف عليه فلفل رومي وصدور الدجاج وبهارات مشكله وملح و الين يستوي بعد مايستوي نتركه الين يبرد بعدها نجيب البطاطس وفرده باليد ونحشيه دجاج وجبنه موزريلا ونكورها نغمسها بالبن او بيض الي تحبون بعدها بالبقسماط الكوري ونقليها وبس بالعافيه❣️ #foryou #السعودية #ترند #food #طبخ

امل⭐️
امل⭐️
Open In TikTok:
Region: SA
Sunday 08 November 2026 19:56:54 GMT
205524
5546
26
825

Music

Download

Comments

dfdyrjfh2467
Sz501 :
وضعي يوم اشتهيت بس ما أقدر آكل ذبحني الوحم
2026-11-09 15:15:44
14
ninjaappksa
Ninja | نينجا :
وش ذا الابدااااع
2026-11-09 06:30:10
17
.xrsw
.xrsw :
م تفك مع القلي؟
2026-11-09 11:37:08
0
user7574636344747
User45797654445689 :
أحس تنفع لرمضان 😍
2026-11-09 14:30:19
1
ffffff4187
المتفائله :
تشهي ماشاءالله
2026-11-09 10:50:45
2
uix_96
uix_96 :
يمي
2026-11-08 23:08:44
1
mimoo00n
✨ مـيـــــــم ✨ :
الساعه ٧ الصباح شسوي بنفسي يعني 😭
2026-11-09 04:54:36
1
canton.ksa
canton | كانتون :
صحه وهنا يا فنانه 😋❤️
2026-11-09 12:29:35
0
11.mo1
مُرادي✨ :
ي ليل اللحين اضيممم مع الاغنيه ولا اجوع
2026-11-11 10:56:52
0
zaena374
زين العابدين :
أول هديه؟؟؟
2026-11-08 20:54:34
0
a2005am0
🤍 :
حلفت ي سميتي اني م اردك اعطيني حبه🥹🌚
2026-11-09 17:35:41
0
wij_009
وِ :
واضح يمي
2026-11-09 03:25:01
1
tia_t40
تـيـاَ 𐙚💗 :
الستوري كيف بالله
2026-11-09 18:51:27
0
To see more videos from user @d.uf9, please go to the Tikwm homepage.

Other Videos

You take a GLP-1, and two headlines land on your feed. The FDA warns about rare vision loss. A new study links stopping a GLP-1 to heart attacks, strokes, or death. So what are you supposed to do about your next dose? Here’s what I want you to take home 👇🏾 1️⃣ The eye condition is rare, but the symptoms are urgent. The FDA flagged a possible increase in nonarteritic anterior ischemic optic neuropathy (NAION). It happens when blood flow to the optic nerve, which carries signals from your eye to your brain, is reduced. Across the trials the FDA reviewed, the rates were about 6 cases per 100,000 people per year in the GLP-1 group and 4 per 100,000 per year in the comparison groups. That’s a difference of about 2 cases per 100,000 people per year. 2️⃣ The stopping study looked at people with type 2 diabetes. Among more than 80,000 adults with type 2 diabetes and no prior cardiovascular disease, those who stopped had more heart attacks, strokes, or deaths combined. Researchers looked back at health records, so the study found a link and couldn’t tell whether stopping itself caused the difference. So what do you do? If the headlines are making you rethink your next dose and you’re feeling well, keep taking your medication as prescribed and bring your questions to your prescriber. If you need to stop, ask what the plan is for managing your blood sugar and heart risk. If vision in one eye suddenly goes dark, gets blurry, or develops a blind spot, get emergency care right away, even if it doesn’t hurt. Save this so you know what to watch for. Follow for practical hospital tips and medical updates that affect you. For general education. Talk with your prescriber about your individual treatment plan. Studies: -FDA safety communication on GLP-1s and rare vision loss (NAION)⁠ -The Lancet Regional Health – Europe study on stopping GLP-1s in people with type 2 diabetes⁠ #g#glp1g#glp1sicknessn#naiond#diabetes
You take a GLP-1, and two headlines land on your feed. The FDA warns about rare vision loss. A new study links stopping a GLP-1 to heart attacks, strokes, or death. So what are you supposed to do about your next dose? Here’s what I want you to take home 👇🏾 1️⃣ The eye condition is rare, but the symptoms are urgent. The FDA flagged a possible increase in nonarteritic anterior ischemic optic neuropathy (NAION). It happens when blood flow to the optic nerve, which carries signals from your eye to your brain, is reduced. Across the trials the FDA reviewed, the rates were about 6 cases per 100,000 people per year in the GLP-1 group and 4 per 100,000 per year in the comparison groups. That’s a difference of about 2 cases per 100,000 people per year. 2️⃣ The stopping study looked at people with type 2 diabetes. Among more than 80,000 adults with type 2 diabetes and no prior cardiovascular disease, those who stopped had more heart attacks, strokes, or deaths combined. Researchers looked back at health records, so the study found a link and couldn’t tell whether stopping itself caused the difference. So what do you do? If the headlines are making you rethink your next dose and you’re feeling well, keep taking your medication as prescribed and bring your questions to your prescriber. If you need to stop, ask what the plan is for managing your blood sugar and heart risk. If vision in one eye suddenly goes dark, gets blurry, or develops a blind spot, get emergency care right away, even if it doesn’t hurt. Save this so you know what to watch for. Follow for practical hospital tips and medical updates that affect you. For general education. Talk with your prescriber about your individual treatment plan. Studies: -FDA safety communication on GLP-1s and rare vision loss (NAION)⁠ -The Lancet Regional Health – Europe study on stopping GLP-1s in people with type 2 diabetes⁠ #g#glp1g#glp1sicknessn#naiond#diabetes

About